BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4572114)

  • 1. High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression.
    Bach MC; Sahyoun A; Adler JL; Schlesinger RM; Breman J; Madras P; P'eng F; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):549-53. PubMed ID: 4572114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical heart transplantation. Orientation after 10 years].
    Struck E; Meisner H; Hagl S; Mendler N; Schmidt-Habelmann P; Sebening F
    Med Klin; 1978 Mar; 73(13):435-46. PubMed ID: 345075
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL; Rao TK; Butt KH
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract]   [Full Text] [Related]  

  • 5. Antirejection drugs and procedures.
    Chatterjee SN
    Am J Surg; 1973 Nov; 126(5):678-82. PubMed ID: 4129988
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement in cadaveric renal transplant survival.
    Beaudoin JG; Guttmann RD; Morehouse DD; Knaack J; Chassot PG
    Arch Surg; 1973 Aug; 107(2):245-9. PubMed ID: 4578273
    [No Abstract]   [Full Text] [Related]  

  • 7. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of ATG in treatment of steroid-resistant rejection.
    Hardy MA; Nowygrod R; Elberg A; Appel G
    Transplantation; 1980 Feb; 29(2):162-4. PubMed ID: 6986690
    [No Abstract]   [Full Text] [Related]  

  • 9. The appearance of reticulum cell sarcoma at the site of antilymphocyte globulin injection.
    Cotton JR; Searls AG; Remmers AR; Lindley JD; Beathard GA; Cottom DL; Fish JC; Townsend CM; Ritzmann SE
    Transplantation; 1973 Aug; 16(2):154-7. PubMed ID: 4581401
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant.
    Mora NP; Klintmalm G; Solomon H; Goldstein RM; Gonwa TA; Husberg BS
    Transplant Proc; 1992 Feb; 24(1):154-5. PubMed ID: 1539220
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical transplantation--an overview.
    Kountz SL
    Transplant Proc; 1973 Mar; 5(1):59-65. PubMed ID: 4572118
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious complications after cardiac transplantation in man.
    Stinson EB; Bieber CP; Griepp RB; Clark DA; Shumway NE; Remington JS
    Ann Intern Med; 1971 Jan; 74(1):22-36. PubMed ID: 4923804
    [No Abstract]   [Full Text] [Related]  

  • 13. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS; Alexander JL; Busch GJ; Murray JE
    Surg Forum; 1969; 20():306-7. PubMed ID: 4192215
    [No Abstract]   [Full Text] [Related]  

  • 14. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternate-day steroids in children after renal transplantation.
    Potter DE; Holliday MA; Wilson CJ; Salvatierra O; Belzer FO
    Transplant Proc; 1975 Mar; 7(1):79-82. PubMed ID: 47201
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 17. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
    Merrill JP
    Kidney Int Suppl; 1975 Feb; (3):318-22. PubMed ID: 1099311
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplantation under cyclophosphamide.
    Starzl TE; Putnam CW; Halgrimson CG; Groth CG; Booth AS; Penn I
    Transplant Proc; 1972 Dec; 4(4):461-4. PubMed ID: 4566786
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of clinical transplantation in patients with end-stage renal disease.
    Belzer FO; Kountz SL
    Transplant Proc; 1973 Mar; 5(1):793-7. PubMed ID: 4121182
    [No Abstract]   [Full Text] [Related]  

  • 20. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.